09/09/2015 // JusticeNewsFlash // (press release)
New York – The release of findings from an NBC Nightly News report has led to questions about C.R. Bard’s Recovery IVC filter product. According to a press release released on Yahoo! Finance, the first part of the series revealed that over 300 adverse events, which include 27 fatalities, have been linked to the device.
The investigation disclosed a confidential study commissioned by the multinational product manufacturer in 2004 that linked the Recovery IVC filter to an increased fatality rate and fracture in comparison with competitors. C.R. Bard reportedly opted to not recall the product despite the report stating that “further investigation” of the issue was “urgently warranted.”
The company reportedly sold more than 34,000 of the products before replacing them with a modified product version that was sold under a different name.
The U.S. Food and Drug Administration disclosed in 2010 that retrievable IVC filters were linked to over 900 adverse events. A new advisory was issued by the agency in 2014 cautioning doctors that the filters should be removed within 29 to 54 days of implantation. However, some are questioning the safety of the product.
A study appeared in JAMA: Internal Medicine indicating that in only 10 percent of patient cases, IVC retrieval was successful.
Dozens of lawsuits have since been filed against C.R. Bard over alleged adverse events connected to the products.
More stories related to The U.S. Food and Drug Administration
Source: Yahoo! Finance News Story Link: http://finance.yahoo.com/news/ivc-filter-lawsuit-news-nbc-165800109.html;_ylt=AwrC1CgYaupVqwoAMhvQtDMD;_ylu=X3oDMTByaWg0YW05BGNvbG8DYmYxBHBvcwM4BHZ0aWQDBHNlYwNzcg–